Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway

Circulation Research

Volumn 101, Issue 11, 2007, Pages 1113-1122

  Guo, Xiaomei ^a,c   Chen, Kuang Hueih ^a,b,d   Guo, Yanhong ^b   Liao, Hua ^c   Tang, Jian ^b   Xiao, Rui Ping ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b PEKING UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Apoptosis; HSG; Mfn 2; PI3K Akt; Vascular smooth muscle cells

Indexed keywords

CASPASE 8; CASPASE 9; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; HYDROGEN PEROXIDE; MITOFUSIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE C; STAUROSPORINE; UNCLASSIFIED DRUG;

ANGIOPLASTY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAROTID ARTERY INJURY; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME RELEASE; INTIMA; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SERUM; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; RATS; UP-REGULATION;

EID: 36348989007     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.107.157644     Document Type: Article

References (40)

1. Nagata S. DNA degradation in development and programmed cell death. Annu Rev Immunol. 2005;23:853-875.
2. Wajant H. The Fas signaling pathway: more than a paradigm. Science. 2002;296:1635-1636.
3. Jiang X, Wang X. Cytochrome C-mediated apoptosis. Annu Rev Biochem. 2004;73:87-106.
4. Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med. 2002;8:1249-1256.
5. Rossi ML, Marziliano N, Merlini PA, Bramucci E, Canosi U, Belli G, Parenti DZ, Mannucci PM, Ardissino D. Different quantitative apoptotic traits in coronary atherosclerotic plaques from patients with stable angina pectoris and acute coronary syndromes. Circulation. 2004;110:1767-1773.
6. Denicourt C, Dowdy SF. Medicine: targeting apoptotic pathways in cancer cells. Science. 2004;305:1411-1413.
7. Gougeon ML. Apoptosis as an HIV strategy to escape immune attack. Nat Rev Immunol. 2003;3:392-404.
8. Meder D, Simons K. Cell biology: Ras on the roundabout. Science. 2005;307:1731-1733.
9. Coleman ML, Marshall CJ, Olson MF. Ras and Rho GTPases in G1-phase cell-cycle regulation. Nat Rev Mol Cell Biol. 2004;5:355-366.
10. Pacold ME, Suire S, Perisic O, Lara-Gonzalez S, Davis CT, Walker EH, Hawkins PT, Stephens L, Eccleston JF, Williams RL. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell. 2000;103:931-943.
11. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev. 1999;13:2905-2927.
12. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997;91:231-241.
13. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296:1655-1657.
14. Chien KR, Hoshijima M. Unravelling Ras signals in cardiovascular disease. Nat Cell Biol. 2004;6:807-808.
15. Work LM, McPhaden AR, Pyne NJ, Pyne S, Wadsworth RM, Wainwright CL. Short-term local delivery of an inhibitor of Ras farnesyltransferase prevents neointima formation in vivo after porcine coronary balloon angioplasty. Circulation. 2001;104:1538-1543.
16. Proud CG. Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy. Cardiovasc Res. 2004;63:403-413.
17. Chen KH, Guo X, Ma D, Guo Y, Li Q, Yang D, Li P, Qiu X, Wen S, Xiao RP, Tang J. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol. 2004;6:872-883.
18. Santel A, Fuller MT. Control of mitochondrial morphology by a human mitofusin. J Cell Sci. 2001;114:867-874.
19. Eura Y, Ishihara N, Yokota S, Mihara K. Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion. J Biochem (Tokyo). 2003;134:333-344.
20. Li PF, Dietz R, von Harsdorf R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation. 1997;96:3602-3609.
21. Ono H, Ichiki T, Ohtsubo H, Fukuyama K, Imayama I, Hashiguchi Y, Sadoshima J, Sunagawa K. Critical role of Mst1 In vascular remodeling after injury. Arterioscler Thromb Vasc Biol. 2005;25:1871-1876.
22. Li RC, Cindrova-Davies T, Skepper JN, Sellers LA. Prostacyclin induces apoptosis of vascular smooth muscle cells by a cAMP-mediated inhibition of extracellular signal-regulated kinase activity and can counteract the mitogenic activity of endothelin-1 or basic fibroblast growth factor. Circ Res. 2004;94:759-767.
23. Champagne MJ, Dumas P, Orlov SN, Bennett MR, Hamet P, Tremblay J. Protection against necrosis but not apoptosis by heat-stress proteins in vascular smooth muscle cells: evidence for distinct modes of cell death. Hypertension. 1999;33:906-913.
24. Janumyan YM, Sansam CG, Chattopadhyay A, Cheng N, Soucie EL, Penn LZ, Andrews D, Knudson CM, Yang E. Bcl-xL /Bcl-2 coordinately regulates apoptosis, cell cycle arrest and cell cycle entry. EMBO J. 2003;22:5459-5470.
25. Ho HK, Hu ZH, Tzung SP, Hockenbery DM, Fausto N, Nelson SD, Bruschi SA. Bcl-xL overexpression effectively protects against tetrafluoroethylcysteine- induced intramitochondrial damage and cell death. Biochem Pharmacol. 2005;69:147-157.
26. Lange H, Suryapranata H, De Luca G, Borner C, Dille J, Kallmayer K, Pasalary MN, Scherer E, Dambrink JH. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med. 2004;350:2673-2681.
27. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Lansky AJ. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 2002;346:957-966.
28. Grise MA, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Cloutier DA, Leon MB. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation. 2002;105:2737-2740.
29. Indolfi C, Avvedimento EV, Rapacciuolo A, Di Lorenzo E, Esposito G, Stabile E, Feliciello A, Mele E, Giuliano P, Condorelli G. Chiariello M. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med. 1995;1:541-545.
30. Wu CH, Lin CS, Hung JS, Wu CJ, Lo PH, Jin G, Shyy YJ, Mao SJT, Chien S. Inhibition of neointimal formation in porcine coronary artery by a Ras mutant. J Surg Res. 2001;99:100-106.
31. Pan SL, Guh JH, Huang YW, Chang YL, Chang CY, Huang LJ, Kuo SC, Teng CM. Inhibition of Ras-mediated cell proliferation by benzyloxybenzaldehyde. J Biomed Sci. 2002;9:622-630.
32. Levin AD, Vukmirovic N, Hwang CW, Edelman ER. Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. Proc Natl Acad Sci U S A. 2004;101:9463-9467.
33. Fattori R, Piva T. Drug-eluting stents in vascular intervention. Lancet. 2003;361:247-249.
34. Durand E, Mallat Z, Addad F, Vilde F, Desnos M, Guerot C, Tedgui A, Lafont A. Time courses of apoptosis and cell proliferation and their relationship to arterial remodeling and restenosis after angioplasty in an atherosclerotic rabbit model. J Am Coll Cardiol. 2002;39:1680-1685.
35. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmouliare A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol. 1995;146:1059-1064.
36. Yang HM, Kim HS, Park KW, You HJ, Jeon SI, Youn SW, Kim SH, Oh BH, Lee MM, Park YB, Walsh K. Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling. Circulation. 2004;110:301-308.
37. Bennett MR. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiolvasc Res. 1999;41:361-368.
38. Malik N, Francis SE, Holt CM, Gunn J, Thomas GL, Shepherd L, Chamberlain J, Newman CM, Cumberland DC, Crossman DC. Apoptosis and cell proliferation after porcine coronary angioplasty. Circulation. 1998;98:1657-1665.
39. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature. 2002;418:934.
40. Davies H, Bignell GR, Cox C, Stephens P, Edkins S. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949-954.